Estimate Recalculated Nov 7, 2024 04:47PM EST
Mark Stanley Berger does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Actinium Pharmaceuticals, Inc., and Genprex, Inc..
Mark Stanley Berger's CIK is 0001700283
2018 was Mark Stanley Berger's most active year for acquiring shares with 4 total transactions. Mark Stanley Berger's most active month to acquire stocks was the month of February. 2024 was Mark Stanley Berger's most active year for disposing of shares, totalling 1 transactions. Mark Stanley Berger's most active month to dispose stocks was the month of January. 2018 saw Mark Stanley Berger paying a total of $209,725.00 for 278,000 shares, this is the most they've acquired in one year. In 2024 Mark Stanley Berger cashed out on 1,319 shares for a total of $5,803.60, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!